The options are listed (there's been churn), expire next year and they're not in the money so I don't think that's the issue.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025